Introduced this decade, the long-acting insulin medications glargine and detemir have largely replaced the older intermediate-acting insulin NPH in the treatment of type 1 diabetes. However, a review of studies reveals that the newer drugs offer only a slight benefit over NPH in terms of blood glucose control.
The researchers did see a clear benefit of long-acting insulin in the risk for hypoglycemia — dangerously low blood glucose that can result from insulin injections —... read more
Submitted by BarryE
There are two completely different diseases known as diabetes. Type 1 is an autoimmune condition that often starts in childhood or adolescence. Type 2 is a metabolic disorder sometimes associated with lifestyle. In both cases, the insulin-secreting beta cells in the pancreas die, albeit at different rates.
Submitted by BarryE
A new program offers deep discounts on brand name and generic drugs. Read more...
Submitted by Amy Tenderich
A Texas mom frustrated with constant insulin injections has invented a device that she said is changing the lives of diabetics.
K.K. Patton invented an injection port and now she only has to feel the pain of the needle stick once every three days.
"When it was something that I was going to have to do for the rest of my life, I was like, 'wow,'" Patton said.
Patton has Type 1 diabetes, which... read more
Submitted by BarryE
A team of Swedish researchers has characterized novel systems properties of insulin signaling in human fat cells. Their mathematical modeling provides further insight into energy level maintenance (via the hormone insulin) within our bodies.
Submitted by BarryE
without healthcare. I myself know someone like this. There are plenty of patient assistance programs designed to help those in need. This is a great program designed to give out free insulin to those in need. You will have to qualify and show proof of need so there is little chance of abusing this program. If you or someone you love needs insulin and cannot afford it, please see the following PDF form for... read more
Submitted by BarryE
Tests suggest that administering insulin for a short period of time at the point of T2 diagnosis is more effective than administering oral drugs to halt and temporarily reverse T2 diabetes. The insulin-treated group took less time to drop to normal glucose levels, and maintained them without medication for longer than those in the oral-medication-treated group. The "full story" link leads to the (free) abstract; the full story requires a subscription to The Lancet.
Submitted by tmana
In the event of a hurricane, flood, or natural disaster, diabetics may be last to be saved. Are you prepared with your own Diabetes Survival Kit?
Submitted by Amy Tenderich
Pfizer Inc and Nektar Therapeutics said on Wednesday clinical trials of the inhaled insulin Exubera found increased cases of lung cancer, leading Nektar to stop seeking a marketing partner for the troubled product and abandon it.
Pfizer said on Wednesday it updated the product's labeling to include a warning with safety information about lung cancer cases found in patients who used Exubera, which U.S. regulators approved in January 2006.
The warning states all patients who... read more
Submitted by TRKnight2007